Covered recipient · General Payments record
LEO BAILEY
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$597.14
- Reported across 23 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $249.65 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $52.28 | 3 |
| Astellas Pharma US Inc | $51.21 | 2 |
| Lilly USA, LLC | $38.60 | 2 |
| PFIZER INC. | $30.81 | 2 |
| DEXCOM, INC. | $28.40 | 1 |
| Novo Nordisk AS | $24.57 | 1 |
| Abbott Laboratories | $23.78 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $23.78 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124852244 | CMS |
| Amgen Inc. | $19.41 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111522795 | CMS |
| Amgen Inc. | $13.47 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117195663 | CMS |
| Amgen Inc. | $19.40 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111522797 | CMS |
| Astellas Pharma US Inc | $19.95 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139404001 | CMS |
| Astellas Pharma US Inc | $31.26 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139416035 | CMS |
| Dexcom, Inc. | $28.40 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153316450 | CMS |
| Lilly USA, LLC | $19.96 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135151556 | CMS |
| Lilly USA, LLC | $18.64 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135124742 | CMS |
| Novo Nordisk Inc | $24.57 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096991839 | CMS |
| PFIZER INC. | $16.35 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131346565 | CMS |
| PFIZER INC. | $14.46 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131519850 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2020, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.